{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A hallmark of Parkinson disease (PD) is the formation of intracellular protein inclusions called Lewy bodies that also contain mitochondria. α-Synuclein (αSyn) is a major protein component of Lewy bodies, where it is in an amyloid conformation and a significant fraction is truncated by poorly understood proteolytic events.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which involves the formation of Lewy bodies containing αSyn in an amyloid conformation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The 20S proteasome produced the C-terminal fragments from both the mutant and wildtype αSyn. These truncations accelerated fibrillization of all α-synucleins, but again there was no clear correlation between the PD-associated mutations and amyloid formation in the presence of liposomes.",
          "judgment": "Yes",
          "reasoning": "The assay class used effectively models the disease pathogenesis/mechanism defined in Step 1, as it involves the interaction between αSyn and the 20S proteasome, which is relevant to the formation of Lewy bodies and αSyn fibrillization.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "At 25 and 50 μM lipids, the conformations of all four proteins are statistically indistinguishable by circular dichroism (data not shown). The fragmentation pattern produced by the 20S proteasome was determined at the lower liposome concentration, where the majority of αSyn is unbound.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay includes appropriate controls (liposome concentrations) and replicates, and the activity of 20S is not affected by liposomes at these concentrations, indicating the assay's validity."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Notably, the rate of formation of the soluble, presumptively cytotoxic oligomers correlated with the disease-associated mutations when both 20S proteasome and liposomes were present. Under these conditions, the wildtype protein was also cleaved and formed the oligomeric structures, albeit at a slower rate, suggesting that 20S-mediated truncation of αSyn.",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the A30P variant, as the presence of both 20S proteasome and liposomes promotes the formation of cytotoxic oligomeric species, which is consistent with the disease mechanism."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P variant in αSyn shows evidence of pathogenicity based on the functional assays described in the paper, which demonstrate an increased rate of cytotoxic oligomer formation in the presence of 20S proteasome and liposomes, consistent with the disease mechanism of Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A hallmark of Parkinson disease (PD) is the formation of intracellular protein inclusions called Lewy bodies that also contain mitochondria. α-Synuclein (αSyn) is a major protein component of Lewy bodies, where it is in an amyloid conformation and a significant fraction is truncated by poorly understood proteolytic events.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which involves the formation of Lewy bodies containing αSyn in an amyloid conformation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The 20S proteasome produced the C-terminal fragments from both the mutant and wildtype αSyn. These truncations accelerated fibrillization of all α-synucleins, but again there was no clear correlation between the PD-associated mutations and amyloid formation in the presence of liposomes.",
          "judgment": "Yes",
          "reasoning": "The assay class used effectively models the disease pathogenesis/mechanism defined in Step 1, as it involves the interaction between αSyn and the 20S proteasome, which is relevant to the formation of Lewy bodies and αSyn fibrillization.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "At 25 and 50 μM lipids, the conformations of all four proteins are statistically indistinguishable by circular dichroism (data not shown). The fragmentation pattern produced by the 20S proteasome was determined at the lower liposome concentration, where the majority of αSyn is unbound.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay includes appropriate controls (liposome concentrations) and replicates, and the activity of 20S is not affected by liposomes at these concentrations, indicating the assay's validity."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Notably, the rate of formation of the soluble, presumptively cytotoxic oligomers correlated with the disease-associated mutations when both 20S proteasome and liposomes were present. Under these conditions, the wildtype protein was also cleaved and formed the oligomeric structures, albeit at a slower rate, suggesting that 20S-mediated truncation of αSyn.",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the E46K variant, as the presence of both 20S proteasome and liposomes promotes the formation of cytotoxic oligomeric species, which is consistent with the disease mechanism."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46K variant in αSyn shows evidence of pathogenicity based on the functional assays described in the paper, which demonstrate an increased rate of cytotoxic oligomer formation in the presence of 20S proteasome and liposomes, consistent with the disease mechanism of Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A hallmark of Parkinson disease (PD) is the formation of intracellular protein inclusions called Lewy bodies that also contain mitochondria. α-Synuclein (αSyn) is a major protein component of Lewy bodies, where it is in an amyloid conformation and a significant fraction is truncated by poorly understood proteolytic events.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, which involves the formation of Lewy bodies containing αSyn in an amyloid conformation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The 20S proteasome produced the C-terminal fragments from both the mutant and wildtype αSyn. These truncations accelerated fibrillization of all α-synucleins, but again there was no clear correlation between the PD-associated mutations and amyloid formation in the presence of liposomes.",
          "judgment": "Yes",
          "reasoning": "The assay class used effectively models the disease pathogenesis/mechanism defined in Step 1, as it involves the interaction between αSyn and the 20S proteasome, which is relevant to the formation of Lewy bodies and αSyn fibrillization.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "At 25 and 50 μM lipids, the conformations of all four proteins are statistically indistinguishable by circular dichroism (data not shown). The fragmentation pattern produced by the 20S proteasome was determined at the lower liposome concentration, where the majority of αSyn is unbound.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay includes appropriate controls (liposome concentrations) and replicates, and the activity of 20S is not affected by liposomes at these concentrations, indicating the assay's validity."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Notably, the rate of formation of the soluble, presumptively cytotoxic oligomers correlated with the disease-associated mutations when both 20S proteasome and liposomes were present. Under these conditions, the wildtype protein was also cleaved and formed the oligomeric structures, albeit at a slower rate, suggesting that 20S-mediated truncation of αSyn.",
          "judgment": "Yes",
          "reasoning": "The functional evidence supports the pathogenicity of the A53T variant, as the presence of both 20S proteasome and liposomes promotes the formation of cytotoxic oligomeric species, which is consistent with the disease mechanism."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T variant in αSyn shows evidence of pathogenicity based on the functional assays described in the paper, which demonstrate an increased rate of cytotoxic oligomer formation in the presence of 20S proteasome and liposomes, consistent with the disease mechanism of Parkinson's disease."
    }
  ]
}